Structured Output Prediction of Anti-cancer Drug Activity

被引:0
|
作者
Su, Hongyu [1 ]
Heinonen, Markus [1 ]
Rousu, Juho [1 ]
机构
[1] Univ Helsinki, Dept Comp Sci, FIN-00014 Helsinki, Finland
来源
关键词
SUPPORT VECTOR MACHINE; CLASSIFICATION;
D O I
暂无
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We present a structured output prediction approach for classifying potential anti-cancer drugs. Our QSAR model takes as input a description of a molecule and predicts the activity against a set of cancer cell lines in one shot. Statistical dependencies between the cell lines are encoded by a Markov network that has cell lines as nodes and edges represent similarity according to an auxiliary dataset. Molecules are represented via kernels based on molecular graphs. Margin-based learning is applied to separate correct multilabels from incorrect ones. The performance of the multilabel classification method is shown in our experiments with NCI-Cancer data containing the cancer inhibition potential of drug-like molecules against 59 cancer cell lines. In the experiments, our method outperforms the state-of-the-art SVM method.
引用
收藏
页码:38 / 49
页数:12
相关论文
共 50 条
  • [1] Anti-cancer Drug Activity Prediction by Ensemble Learning
    Tolan, Ertan
    Tan, Mehmet
    KDIR: PROCEEDINGS OF THE 8TH INTERNATIONAL JOINT CONFERENCE ON KNOWLEDGE DISCOVERY, KNOWLEDGE ENGINEERING AND KNOWLEDGE MANAGEMENT - VOL. 1, 2016, : 431 - 436
  • [2] A computational model for anti-cancer drug sensitivity prediction
    Zhao, Zheming
    Li, Kezhi
    Toumazou, Chris
    Kalofonou, Melpomeni
    2019 IEEE BIOMEDICAL CIRCUITS AND SYSTEMS CONFERENCE (BIOCAS 2019), 2019,
  • [3] Reliable anti-cancer drug sensitivity prediction and prioritization
    Lenhof, Kerstin
    Eckhart, Lea
    Rolli, Lisa-Marie
    Volkamer, Andrea
    Lenhof, Hans-Peter
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [4] An Integrated Approach to Anti-Cancer Drug Sensitivity Prediction
    Berlow, Noah
    Haider, Saad
    Wan, Qian
    Geltzeiler, Mathew
    Davis, Lara E.
    Keller, Charles
    Pal, Ranadip
    IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS, 2014, 11 (06) : 995 - 1008
  • [5] Pharmacogenetic determinants of anti-cancer drug activity and toxicity
    Danesi, R
    De Braud, F
    Fogli, S
    Di Paolo, A
    Del Tacca, M
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (08) : 420 - 426
  • [6] Network-based prediction of anti-cancer drug combinations
    Jiang, Jue
    Wei, Xuxu
    Lu, Yukang
    Li, Simin
    Xu, Xue
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [7] Ensemble transfer learning for the prediction of anti-cancer drug response
    Zhu, Yitan
    Brettin, Thomas
    Evrard, Yvonne A.
    Partin, Alexander
    Xia, Fangfang
    Shukla, Maulik
    Yoo, Hyunseung
    Doroshow, James H.
    Stevens, Rick L.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [8] METHODOLOGICAL APPROACH TO THE PREDICTION OF ANTI-CANCER DRUG EFFECT IN HUMANS
    DURKIN, WJ
    GHANTA, VK
    BALCH, CM
    DAVIS, DW
    HIRAMOTO, RN
    CANCER RESEARCH, 1979, 39 (02) : 402 - 407
  • [9] Ensemble transfer learning for the prediction of anti-cancer drug response
    Yitan Zhu
    Thomas Brettin
    Yvonne A. Evrard
    Alexander Partin
    Fangfang Xia
    Maulik Shukla
    Hyunseung Yoo
    James H. Doroshow
    Rick L. Stevens
    Scientific Reports, 10
  • [10] Trypanocidal activity of the proteasome inhibitor and anti-cancer drug bortezomib
    Dietmar Steverding
    Xia Wang
    Parasites & Vectors, 2